FREE Daily Stock Alerts From Stock-PR.com
Power3 Medical Products, Inc. (OTC:PWRM)
Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroProÂ®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
Breast cancer is cancer arising in breast tissue. Cancer is simply a group of abnormal cells that have abnormal growth patterns. Although breast cancer is primarily a disease of women, almost 1% of breast cancers occur in men. Breast cancer is the most common type of cancer in women with the exception of melanoma skin cancers. It is the second leading cause of death by cancer in women.
BC-SeraPro™ is a proteomic test for the diagnosis of breast cancer. This test is designed to measure the quantitative expression level of 22 protein biomarkers in the serum that differentiate between breast cancer patients and control subjects. The level of the biomarkers from the patient's serum sample is compared to the Power3 Medical Products' patient database. Statistical analysis by linear discriminate function will analyze the biomarker levels of the patient sample and assign a probability score for the diagnosis of the patient sample. Probability score is ranged from 0.0 to 1.0. Results of the BC-SeraPro™ test should not be considered a standalone diagnosis nor a guarantee and is intended to be used in conjunction with mammography and other accepted modalities.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease).
Please visit Power3 Medical Products, Inc website http://www.power3medical.com.
Invacare Corporation (NYSE:IVC) announced that it has determined that its 4.125% Convertible Senior Subordinated Debentures due 2027 (CUSIP No. 461203AD3) (the "Convertible Debentures") have become convertible at the option of the holders beginning on July 1, 2011 and will remain convertible through September 30, 2011, as provided in the Indenture relating to the Convertible Debentures, dated as of February 12, 2007, between Invacare and Wells Fargo Bank, N.A., as Trustee (the "Indenture").
Invacare Corporationheadquartered in Elyria, Ohio, is the global leader in the manufacture and distribution of innovative home and long-term care medical products that promote recovery and active lifestyles. For more information about the company and its products, visit Invacare's website at www.invacare.com.
Senior Housing Properties Trust (NYSE:SNH) announced its regular quarterly common share dividend of $0.37 per common share ($1.48 per share per year). The regular quarterly dividend will be paid to common shareholders of record as of the close of business on July 11, 2011 and distributed on or about August 12, 2011.
Senior Housing Properties Trust is a real estate investment trust, or REIT, which principally owns private pay senior living communities and medical office buildings located throughout the United States. SNH is headquartered in Newton, MA.
RPM International Inc. (NYSE:RPM) announced that its board of directors has declared a regular quarterly cash dividend of $0.21 per share, payable on July 29, 2011 to stockholders of record as of July 15, 2011.
RPM International Inc., a holding company, owns subsidiaries that are world leaders in specialty coatings, sealants, building materials and related services serving both industrial and consumer markets.
APAC Customer Services, Inc. (NASDAQ:APAC), a leader in global outsourced services and solutions, has opened a new contact center in Montevideo, Uruguay. The site is located in Aguada Park, an international center for global services situated in the free zone area of Montevideo. APAC will occupy three floors of the newly constructed building with initial capacity for 630 customer service associate workstations.
APAC Customer Services, Inc. is a leading provider of quality customer care services and solutions for market leaders in healthcare, business services, communications, media & publishing, travel & entertainment and financial services industries. APAC's comprehensive web site is at http://www.apaccustomerservices.com.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).
Sign Up For Free Stock Alerts At http://stock-pr.com/signup